Inferring selection in the Anopheles gambiae species complex: an example from immune-related serine protease inhibitors

被引:22
|
作者
Obbard, Darren J. [1 ]
Welch, John J. [1 ]
Little, Tom J. [1 ]
机构
[1] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland
来源
MALARIA JOURNAL | 2009年 / 8卷
基金
英国惠康基金; 英国生物技术与生命科学研究理事会;
关键词
GENETIC DIFFERENTIATION; DROSOPHILA-MELANOGASTER; MOLECULAR EVOLUTION; POSITIVE SELECTION; MALARIA VECTORS; HAPLOTYPE RECONSTRUCTION; NUCLEOTIDE VARIABILITY; POPULATION-GENETICS; ADAPTIVE EVOLUTION; STATISTICAL-METHOD;
D O I
10.1186/1475-2875-8-117
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Mosquitoes of the Anopheles gambiae species complex are the primary vectors of human malaria in sub-Saharan Africa. Many host genes have been shown to affect Plasmodium development in the mosquito, and so are expected to engage in an evolutionary arms race with the pathogen. However, there is little conclusive evidence that any of these mosquito genes evolve rapidly, or show other signatures of adaptive evolution. Methods: Three serine protease inhibitors have previously been identified as candidate immune system genes mediating mosquito-Plasmodium interaction, and serine protease inhibitors have been identified as hot-spots of adaptive evolution in other taxa. Population-genetic tests for selection, including a recent multi-gene extension of the McDonald-Kreitman test, were applied to 16 serine protease inhibitors and 16 other genes sampled from the An. gambiae species complex in both East and West Africa. Results: Serine protease inhibitors were found to show a marginally significant trend towards higher levels of amino acid diversity than other genes, and display extensive genetic structuring associated with the 2La chromosomal inversion. However, although serpins are candidate targets for strong parasite-mediated selection, no evidence was found for rapid adaptive evolution in these genes. Conclusion: It is well known that phylogenetic and population history in the An. gambiae complex can present special problems for the application of standard population-genetic tests for selection, and this may explain the failure of this study to detect selection acting on serine protease inhibitors. The pitfalls of uncritically applying these tests in this species complex are highlighted, and the future prospects for detecting selection acting on the An. gambiae genome are discussed.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] From tumor to tolerance: A comprehensive review of immune checkpoint inhibitors and immune-related adverse events
    Sutanto, Henry
    Safira, Ardea
    Fetarayani, Deasy
    ASIA PACIFIC ALLERGY, 2024, 14 (03) : 124 - 138
  • [32] Strain- and species-specific comparison of the immune responses of different members of the Anopheles gambiae complex to Plasmodium falciparum infection
    Baton, Luke A.
    Dong, Yuemei
    Dimopoulos, George
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2006, 75 (05): : 311 - 311
  • [33] Physician awareness of immune-related adverse events from checkpoint inhibitors.
    Khalid, Ahmed Bilal
    Jalal, Shadia Ibrahim
    Drum, Greg Andrew
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [34] HIDDEN SPECIES BOUNDARIES AMONG MOSQUITOES OF THE MALARIA-TRANSMITTING ANOPHELES GAMBIAE COMPLEX FROM BURKINA FASO
    Tennessen, Jacob A.
    Ingham, Victoria A.
    Toe, Hyacinthe K.
    Sagnon, N'Fale
    Ranson, Hilary
    Neafsey, Daniel E.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2019, 101 : 385 - 385
  • [35] Immune-Related Adverse Events of Immune Checkpoint Inhibitors-From a Clinical to Pathophysiological View Reply
    Berner, Fiamma
    Bomze, David
    Flatz, Lukas
    JAMA ONCOLOGY, 2019, 5 (12) : 1805 - 1805
  • [36] Endocrine toxicities of immune checkpoint inhibitors: What differs from other immune-related adverse events
    Lecoq, A. L.
    Becquemont, L.
    Chanson, P.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 : 134 - 134
  • [37] Pharmacogenomic prediction of immune-related adverse events from immune checkpoint inhibitors among Asian patients
    Huang, Yiqing
    Aminkeng, Folefac
    Wong, Alvin S. C.
    Tay, Sen Hee
    Zhao, Joseph J.
    Ang, Yvonne
    Soo, Ross A.
    Goh, Boon Cher
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [38] Safety of thoracic radiotherapy in patients with prior immune-related adverse events from immune checkpoint inhibitors
    Shaverdian, N.
    Beattie, J.
    Thor, M.
    Offin, M.
    Shepherd, A. F.
    Gelblum, D. Y.
    Wu, A. J.
    Simone, C. B., II
    Hellmann, M. D.
    Chaft, J. E.
    Rimner, A.
    Gomez, D. R.
    ANNALS OF ONCOLOGY, 2020, 31 (12) : 1719 - 1724
  • [39] Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database
    Ruggiero, Rosanna
    Fraenza, Federica
    Scavone, Cristina
    di Mauro, Gabriella
    Piscitelli, Raffaele
    Mascolo, Annamaria
    Ferrajolo, Carmen
    Rafaniello, Concetta
    Sportiello, Liberata
    Rossi, Francesco
    Capuano, Annalisa
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [40] STIMULATION OF A SERINE PROTEASE TARGETING THE LRIM1/APL1C COMPLEX REVEALS SPECIFICITY IN COMPLEMENT-LIKE PATHWAY ACTIVATION IN ANOPHELES GAMBIAE
    Povelones, Michael
    Farrant, Katie V.
    Christophides, George K.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2015, 93 (04): : 417 - 417